Some Novel Aspects of the Function of Prostaglandin E2 in the Coronary Circulation

  • Thomas H. Hintze
  • Gabor Kale
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


Recently, much work has centered on the effects and possible physiological and pathological importance of coronary prostacyclin synthesis (Fitzpatrick et al., 1978; Hyman et al., 1978; Needleman and Kaley, 1978; Dusting et al., 1979; Lefer et al., 1979; Aiken et al., 1980; Jugdutt et al., 1981). Prostacyclin, however, is not the only cyclooxygenase product that is produced in the coronary vasculature. In this context, recent work by Gerritsen and Printz (1981) has shown that PGE2 is produced in large coronary arteries, coronary micro vessels, and also in microvas-cular endothelial cells (Gerritsen and Cheli, 1984). Additionally, we have demonstrated that PGE2 has potent effects on coronary blood flow (Hintze and Kaley, 1977) and under special conditions may activate cardiac ventricular receptors, leading to reflex effects on the circulation in general (Hintze and Kaley, 1984). Furthermore, Jugdutt et al. (1981) have shown that infusions of PGE1 ameliorate some of the harmful consequences of ischemia on the myocardium. The purpose of this chapter is to review the effects of PGE2 on the myocardium and coronary circulation and to describe our own, more recent observations on the effects of PGE2 on blood flow distribution in the myocardium, on large coronary vessels in conscious dogs, and on the possible reflex regulation of circulatory function.


Arachidonic Acid Left Anterior Descend Coronary Blood Flow Coronary Circulation Circumflex Coronary Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Afonso, S., Bandow, G.T., and Rowe, G.G., 1974, Indomethacin and the prostaglandin hypothesis of coronary flow regulation, J. Physiol. (Lond.) 241:299–308.Google Scholar
  2. Aiken, J.W., Shebuski, R.J., and Gorman, R.R., 1980, Blockage of partially obstructed coronary arteries with platelet thrombi: Comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin, Adv. Prostaglandin Thromboxane Res. 7:635–639.PubMedGoogle Scholar
  3. Alexander, R.W. Kent, K.M., Pisano, J.J., Keiser, H.R., and Cooper, T., 1975, Regulation of postocclusion hyperemia by endogenously synthesized prostaglandins in the dog heart, J. Clin. Invest. 55:1174–1181.PubMedCrossRefGoogle Scholar
  4. Becker, L., 1976, Effects of tachycardia on left ventricular blood flow distribution during coronary artery occlusion, Am. J. Physiol. 230:1072–1077.PubMedGoogle Scholar
  5. Becker, L.C, Ferreira, R., and Thomas, M., 1973, Mapping of left ventricular blood flow with radioactive microspheres in experimental coronary artery occlusion, Cardiovasc. Res. 7:391–400.PubMedCrossRefGoogle Scholar
  6. Belloni, F.L., 1979, The local control of coronary blood flow, Cardiovasc. Res. 13:63–85.PubMedCrossRefGoogle Scholar
  7. Berger, H.J., Zaret, B.L., Speroff, L., Cohen, L.S., and Wolfson, S., 1976, Regional and cardiac prostaglandin release during myocardial ischemia in anesthetized dog, Circ. Res. 38:566–569.PubMedCrossRefGoogle Scholar
  8. Bloor, C.M., White, F.C, and Sobel, B.E., 1973, Coronary and systemic effects of prostaglandins in the unanesthetized dog, Cardiovasc. Res. 7:156–166.PubMedCrossRefGoogle Scholar
  9. Buckberg, G.D., Luck, J.C, Payne, B.D., Hoffman, J.I.E., Archie, J.P., and Fixier, D.E., 1971, Some sources of error in measuring regional blood flow with radioactive microspheres, J. Appl. Physiol. 31:598–604.PubMedGoogle Scholar
  10. Carlson, L.A., and Örö, L., 1966, Effect of prostaglandin E1 on blood pressure and heart rate in the dog, Acta. Physiol. Scand. 67:89–99.PubMedCrossRefGoogle Scholar
  11. Chappie, D.J., Dusting, G.J., Hughes, R., and Vane, J.R., 1978, A vagal reflex contributes to the hypotensive effect of prostacyclin in anesthetized dogs, Br. J. Pharmacol. 68:437–447.CrossRefGoogle Scholar
  12. Chen, D., Donald, D. E., and Romero, J. C, 1979, Role of vagal afferents in the vasodepressor effects of PGE2 in the spontaneously hypertensive rat, Am. J. Physiol. 236:H635–H639.PubMedGoogle Scholar
  13. Chiavarelli, S., Moncada, S., and Mullane, K.M., 1982, Prostacyclin can either increase or decrease heart rate depending on the basal state, Br. J. Pharmacol. 75:243–249.PubMedCrossRefGoogle Scholar
  14. Chiba, S., and Malik, K.U., 1980, Mechanism of the chronotropic effects of prostacyclin in the dog, J. Pharmacol. Exp. Ther. 213:261–266.PubMedGoogle Scholar
  15. Coker, S.J., Marshall, R.J., Parratt, J.R., and Zeitlin, I.J., 1981, Does the local myocardial release of prostaglandin E2 or F contribute to the early consequences of acute myocardial ischemia, J. Mol. Cell Cardiol. 13:425–434.PubMedCrossRefGoogle Scholar
  16. Coleridge, H.M., and Coleridge, J.C.G., 1980, Cardiovascular afferents involved in regulation of peripheral vessels, Annu. Rev. Physiol. 42:413–427.PubMedCrossRefGoogle Scholar
  17. Coleridge, H.M., Coleridge, J.C.G., Ginzel, K.H., Baker, D.G., Banzett, R.B., and Morrison, M.A., 1976, Stimulation of “irritant” receptors and afferent C-fibers in the lungs by prostaglandins, Nature 264:451–453.PubMedCrossRefGoogle Scholar
  18. Domench, R.J., Hoffman, J.I.E., Noble, M.I., Saunders, K.B., Henson, J.R., and Subijanto, S., 1969, Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs, Circ. Res. 25:581–595.CrossRefGoogle Scholar
  19. Dusting, G.J., Moncada, S., and Vane, J.R., 1977, Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid, Prostaglandins 13:3–15.PubMedCrossRefGoogle Scholar
  20. Dusting, G.J., Moncada, S., and Vane. J.R., 1979, Prostaglandins, their intermediates and precursors; cardiovascular actions and regulatory roles in normal and abnormal circulatory systems, Prog. Cardiovasc. Dis. 21:405–430.PubMedCrossRefGoogle Scholar
  21. Dusting, G. J., and Vane, J. R., 1980, Some cardiovascular properties of prostacyclin (PGI2) which are not shared with PGE2, Circ. Res. 46(Suppl. 1):183–187.Google Scholar
  22. Fitzpatrick, T.M., Alter, I., Corey, E.J., Ramwell, P.W., Rose, J.C, and Kot, P.A., 1978, Cardiovascular responses to PGI2 (prostacyclin) in the dog, Circ. Res. 42:192–194.PubMedCrossRefGoogle Scholar
  23. Furchgott, R.L., and Zawadski, D., 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 288:373–376.PubMedCrossRefGoogle Scholar
  24. Gerritsen, M.E., and Cheli, C.D., 1984, Arachidonic acid and endoperoxide metabolism in isolated rabbit coronary microvessels and isolated and cultivated coronary microvessel endothelial cells, J.Clin. Invest. 72:1658–1671.CrossRefGoogle Scholar
  25. Gerritsen, M.E., and Printz, M.P., 1981, Sites of prostaglandin synthesis in bovine heart and isolated bovine coronary microvessels, Circ. Res. 49:1152–1163.PubMedCrossRefGoogle Scholar
  26. Giles, R.W., and Wilcken, E.L., 1977, Reactive hyperaemia in the dog heart: Inter-relations between adenosine, ATP and aminophylline and the effect of indomethacin, Cardiovasc. Res. 11:113–121.PubMedCrossRefGoogle Scholar
  27. Giles, T.D., Quiroz, A.C, and Burch, G.E., 1969, The effects of prostaglandin E1 on the systemic and pulmonary circulations of intact dogs. The influence of urethane and pentobarbital anesthesia, Experientia 25:1056–1069.PubMedCrossRefGoogle Scholar
  28. Greenberg, R.A., and Sparks, H.V., 1969, Prostaglandins and consecutive vascular segments of the canine hindlimb, Am. J. Physiol. 216:567–571.PubMedGoogle Scholar
  29. Harlan, D. M., Rooke, T. N., Belloni, F. L., and Sparks, H. V., 1978, Effects of indomethacin on coronary vascular response to increased myocardial oxygen consumption, Am. J. Physiol. 235:4372–4378.Google Scholar
  30. Heymann, M.A., Payne, B.D., Hoffman, J.I.E., and Rudolph, A.M., 1977, Blood flow measurements with radio-labelled particles, Prog. Cardiovasc. Dis. 20:55–79.PubMedCrossRefGoogle Scholar
  31. Higgins, C.B., Vatner, S.F., Franklin, D., Patrick, T., and Braunwald, E., 1971, Effects of prostaglandin A2 on systemic and coronary circulations in the dog, Circ. Res. 28:638–647.PubMedCrossRefGoogle Scholar
  32. Hintze, T.H., and Kaley, G., 1977, Prostaglandins and the control of blood flow in the canine myocardium, Circ. Res. 40:313–319.PubMedCrossRefGoogle Scholar
  33. Hintze, T.H., and Kaley, G., 1984, Ventricular receptors activated following myocardial prostaglandin synthesis initiate reflex hypotension, reduction in heart rate, and redistribution of cardiac output in the dog, Circ. Res. 54:239–247.PubMedCrossRefGoogle Scholar
  34. Hintze, T.H., and Vatner, S.F., 1984, Reactive dilation of large coronary arteries in conscious dogs, Circ. Res. 54:50–57.PubMedCrossRefGoogle Scholar
  35. Hintze, T.H., Martin, E.G., Messina, E.J., and Kaley, G., 1979, Prostacyclin (PGI2) elicits reflex bradycardia in dogs: Evidence for vagal mediation, Proc. Soc. Exp. Biol. Med. 162:96–100.PubMedGoogle Scholar
  36. Hintze, T.H., Panzenbeck, M.J., Messina, E.J., and Kaley, G., 1981, Prostacyclin (PGI2) lowers heart rate in the conscious dog, Cardiovasc. Res. 15:538–546.PubMedCrossRefGoogle Scholar
  37. Hintze, T. H., Martin, E. G., Messina, E. J., and Kaley, G., 1982, Cardiovascular reflex actions of arachidonic acid metabolites: Activation of a vagal depressor reflex by prostacyclin (PGI2) in the dog, in: Cardiovascular Pharmacology of the Prostaglandins (P. M. Vanhoutte, H. Denolin, and A. Goossens, eds.), Raven Press, New York, pp. 417–437.Google Scholar
  38. Hintze, T.H., Kaley, G., and Panzenbeck, M.J., 1984, Mechanisms of reflex bradycardia and hypotension by metabolites of arachidonic acid in the cat, Br. J. Pharmacol. 82:117–125.PubMedCrossRefGoogle Scholar
  39. Hintze, T. H., Kichuk, M. R., Stern, H., and Kaley, G., 1985, Dilation of large coronary arteries in conscious dogs by prostacyclin, Adv. Prostaglandin Thromboxane and Leukotriene Res. (G. V. R. Born et al.), Raven Press, New York, pp. 341–344.Google Scholar
  40. Hutton, I., Parratt, J.R., and Lawrie, T.D.V., 1973, Cardiovascular effects of prostaglandin E2 in experimental myocardial infarction, Cardiovasc. Res. 7:149–155.PubMedCrossRefGoogle Scholar
  41. Hyman, A.L., Kadowitz, P.J., Lands, W.E.M., Crawford, G.G., Fried, J., and Barton, J., 1978, Coronary vasodilator activity of 13,14-dehydro prostacyclin methylester: Comparison with pros-tacyclin and other prostanoids, Proc. Nad. Acad. Sci. U.S.A. 75:3522–3526.CrossRefGoogle Scholar
  42. Jentzer, J. H., Sonnenblick, E. H., and Kirk, E. S., 1979, Coronary and systemic vasomotor effects of prostacyclin: Implications for the ischemic myocardium, in: Prostacyclin (J. R. Vane and S. Bergström, eds.), Raven Press, New York, pp. 323–338.Google Scholar
  43. Jugdutt, B.I., Hutchins, G.M., Bulkley, B.H., and Becker, L.C, 1981, Dissimilar effects of prostacyclin, prostaglandin E1 and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs, Circ. Res. 49:685–700.PubMedCrossRefGoogle Scholar
  44. Kaley, G., Hintze, T.H., and Messina, E.J., 1980, Role of prostaglandins in ventricular reflexes, Adv. Prostaglandin Thromboxane Res. 7:601–608.PubMedGoogle Scholar
  45. Kaley, G., Messina, E.J., and Hintze, T.H., 1981, Role of prostaglandins in the regulation of blood pressure and blood flow, Adv. Physiol. Sci. 7:83–90.Google Scholar
  46. Kraemer, R.J., Phernetton, J.M., and Folts, J.D., 1976, Prostaglandin-like substances in coronary venous blood following myocardial ischemia, J. Pharmacol. Exp. Ther. 199:611–619.PubMedGoogle Scholar
  47. Kulkarni, P.S., Roberts, R., and Needleman, P., 1976, Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate, Prostaglandins 12:337–352.PubMedCrossRefGoogle Scholar
  48. Leach, B.E., Armstrong, F.B., Germain, G.S., and Muirhead, E.E., 1973, Vasodepressor action of prostaglandin A2 and E2 in the spontaneously hypertensive rat (SHR): Evidence for an action mediated by the vagus, J. Pharmacol. Exp. Ther. 185:479–485.PubMedGoogle Scholar
  49. Lefer, A.M., Ogletree, M.L., Smith, J.B., Silver, M.J., Nicoloau, K.C, Barnette, W.E., and Gasic, G.C, 1979, Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia, Science 200:52–54.CrossRefGoogle Scholar
  50. Maxwell, G., 1967, The effects of prostaglandin E2 upon the general and coronary hemodynamics in the intact dog, Br. J. Pharmacol. Chemother. 31:162–168.PubMedGoogle Scholar
  51. Nakano, J., 1968, Effects of prostaglandin A1, E1, and F on the coronary and peripheral circulations, Proc. Soc. Exp. Biol. Med. 127:1160–1163.PubMedGoogle Scholar
  52. Needleman, P., and Kaley, G., 1978, Cardiac and coronary prostaglandin synthesis and function, N. Engl. J. Med. 298:1122–1128.PubMedCrossRefGoogle Scholar
  53. Nutter, P.O., and Crumly, H.J., 1972, Canine coronary vascular and cardiac responses to the prostaglandins, Cardiovasc. Res. 6:217–225.PubMedCrossRefGoogle Scholar
  54. Ogletree, M. L., Smith, J. B., and Lefer, A. M., 1978, Actions of prostaglandins on isolated perfused cat coronary arteries, Am. J. Physiol. 235:H400–H406.PubMedGoogle Scholar
  55. Owen, T.L., Ehrhart, I.C, Weidner, W.J., Scott, J.B., and Haddy, F.J., 1975, Effects of indomethacin on local blood flow regulation in canine heart and kidney, Proc. Soc. Exp. Biol. Med. 149:871–876.PubMedGoogle Scholar
  56. Parratt, J.R., and Marshall, R.J., 1978, Are prostaglandms involved in the regulation of coronary blood flow? A review of the evidence, Acta Biol. Med. Germ. 37:747–760.PubMedGoogle Scholar
  57. Rowe, G.G., and Afonso, S., 1974, Systemic and coronary hemodynamic effects of intracoronary administration of prostaglandins E1 and E2, Am. Heart J. 88:51–60.PubMedCrossRefGoogle Scholar
  58. Rubio, R., and Berne, R.M., 1975, Regulation of coronary blood flow, Prog. Cardiovasc. Dis. 18:105–110.PubMedCrossRefGoogle Scholar
  59. Rudolph, A.M., and Heymann, M.A., 1967, The circulation of the fetus in utero, Circ. Res. 16:163–184.CrossRefGoogle Scholar
  60. Strong, G.G., and Bohr, D.F., 1967, Effects of prostaglandins E1, E2, A2 and F on isolated vascular smooth muscle, Am. J. Physiol. 213:725–733.PubMedGoogle Scholar
  61. Sunahara, F.A., and Talesnik, J., 1979, Myocardial synthesis of prostaglandin-like substances and coronary reactions to cardiostimulation and to hypoxia, Br. J. Pharmacol. 65:71–85.PubMedCrossRefGoogle Scholar
  62. Uchida, Y., and Murao, S., 1979, Effect of prostaglandin I2 on cyclical reductions of coronary blood flow, Jpn. Circ. J. 43:645–652.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Thomas H. Hintze
    • 1
  • Gabor Kale
    • 1
  1. 1.Department of PhysiologyNew York Medical CollegeValhallaUSA

Personalised recommendations